Dr.rer.nat. Claudia Zelle-Rieser

  • +43 (512) 570485-17
  • +43 (512) 570485-44

list of publications

Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative cooperativity of the receptors

Ganghammer S, Gutjahr J, Hutterer E, Krenn PW, Pucher S, Zelle-Rieser C, Jöhrer K, Wijtmans M, Leurs R, Smit MJ, Gattei V, Greil R, Hartmann TN

Haematologica 20 Nov 2015; (). [Epub ahead of print]

Bone marrow microenvironmental CD4 + and CD8 + lymphocyte infiltration patterns define overall- and progression free survival in standard risk multiple myeloma - an analysis from the Austrian Myeloma Registry

Willenbacher W, Willenbacher E, Zelle-Rieser C, Biedermann R, Weger R, Jöhrer K, Brunner A

Leuk Lymphoma 16 Nov 2015; (). [Epub ahead of print]

Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.

Jöhrer K, Obkircher M, Neureiter D, Parteli J, Zelle-Rieser C, Maizner E, Kern J, Hermann M, Hamacher F, Merkel O, Wacht N, Zidorn C, Scheideler M, Greil R.

Mol Med (Berl). 1 Jun 2012; 90(6)681-93.

Chemokine-dependent B cell-T cell interactions in chronic lymphocytic leukemia and multiple myeloma - targets for therapeutic intervention?

Jöhrer K, Hofbauer SW, Zelle-Rieser C, Greil R, Hartmann TN.

Expert Opin Biol Ther. 1 Apr 2012; 12(4)425-41.

Tumour-immune cell interactions modulated by chemokines.

Jöhrer K, Pleyer L, Olivier A, Maizner E, Zelle-Rieser C, Greil R.

Expert Opin Biol Ther. 22 Dec 2008; 8(3)269-90.

Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma.

Johrer K, Zelle-Rieser C, Perathoner A, Moser P, Hager M, Ramoner R, Gander H, Holtl L, Bartsch G, Greil R, Thurnher M.

Clin Cancer Res. 1 Apr 2005; 11(7)2459-65.

Defective T-helper cell function after T-cell-depleting therapy affecting naive and memory populations.

Heitger A, Winklehner P, Obexer P, Eder J, Zelle-Rieser C, Kropshofer G, Thurnher M, Holter W.

Blood 1 Jun 2002; 99(11)4053-62.